Immune dysregulation underpins radioresistance in nasopharyngeal carcinoma (NPC).

52Background: Radiotherapy (RT) is a primary modality in the treatment of NPC. However, 30% of patients present with disease recurrence following RT of this radiosensitive tumor. Here, we investiga...